[HTML][HTML] Antibody responses to natural SARS-CoV-2 infection or after COVID-19 vaccination
H Altawalah - Vaccines, 2021 - mdpi.com
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
the causative agent of the ongoing pandemic of coronavirus disease 2019 (COVID-19). The …
the causative agent of the ongoing pandemic of coronavirus disease 2019 (COVID-19). The …
[HTML][HTML] COVID-19 vaccines, effectiveness, and immune responses
HI Abufares, L Oyoun Alsoud, MAY Alqudah… - International journal of …, 2022 - mdpi.com
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has captivated the globe's attention since its emergence in 2019. This highly …
(SARS-CoV-2), has captivated the globe's attention since its emergence in 2019. This highly …
[HTML][HTML] COVID-19 vaccines
D Ndwandwe, CS Wiysonge - Current opinion in immunology, 2021 - Elsevier
Highlights•COVID-19 vaccine development has accelerated at an incredible rate with 105
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …
Influence of age, gender, previous SARS-CoV-2 infection, and pre-existing diseases in antibody response after COVID-19 vaccination: A review
MCR Fernandes, GS Vasconcelos, ACL de Melo… - Molecular …, 2023 - Elsevier
Vaccines induce specific long-term immunological memory against pathogens, preventing
the worsening of diseases. The COVID-19 health emergency has caused more than 6 …
the worsening of diseases. The COVID-19 health emergency has caused more than 6 …
[HTML][HTML] COVID-19 vaccines currently under preclinical and clinical studies, and associated antiviral immune response
With a death toll of over one million worldwide, the COVID-19 pandemic caused by SARS-
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …
Vaccines for COVID-19
JS Tregoning, ES Brown… - Clinical & …, 2020 - academic.oup.com
Since the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019,
there has been an explosion of vaccine development. By 24 September 2020, a staggering …
there has been an explosion of vaccine development. By 24 September 2020, a staggering …
[HTML][HTML] Humoral immune responses in COVID-19 patients: a window on the state of the art
G Siracusano, C Pastori, L Lopalco - Frontiers in immunology, 2020 - frontiersin.org
The novel SARS-CoV-2 is a recently emerging virus causing a human pandemic. A great
variety of symptoms associated with COVID-19 disease, ranging from mild to severe …
variety of symptoms associated with COVID-19 disease, ranging from mild to severe …
[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
R Singh, A Kang, X Luo, M Jeyanathan… - The FASEB …, 2021 - ncbi.nlm.nih.gov
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …
century. In 11 months since its first emergence, according to WHO, the causative infectious …
[HTML][HTML] A Covid-19 milestone attained—a correlate of protection for vaccines
A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
Q He, Q Mao, C An, J Zhang, F Gao, L Bian… - Emerging microbes & …, 2021 - Taylor & Francis
ABSTRACT COVID-19 vaccines emerging from different platforms differ in efficacy, duration
of protection, and side effects. To maximize the benefits of vaccination, we explored the …
of protection, and side effects. To maximize the benefits of vaccination, we explored the …